Insider Trading › SGMO › Insiders
SGMO
SGMO·Insider activity
$0.07
+0.00 (+0.00%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
SGMO
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
SGMOS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
In the last 180 days, SGMO insiders filed 0 purchases ($0) and 2 sales ($107K) on the open market, by 2 insiders. Newest filing Apr 23, 2026 (5 months ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by SGMO insiders · Form 4 · last two years
On Record
$0Purchases · 180 days
$107KSales · 180 days
1,173Open-market transactions on record
2Insiders filing · 180 days
Purchases (code P) and sales (code S) of SGMO common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
1,173 on record · newest trade first · the newest 300 shown
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| Davis Gregory DHead of Research & Technology | Sale | −69.8K | $0.25 | $17K | 115.3Kdirect | Apr 22, 2026 | Apr 23, 2026 | Form 4 ↗ |
| Dubois-Stringfellow NathalieSVP-CHIEF DEVELOPMENT OFFICER | Sale | −345.9K | $0.26 | $90K | 332.8Kdirect | Apr 21, 2026 | Apr 23, 2026 | Form 4 ↗ |
| BIOGEN INC.10% owner | Sale | −6.0M | n/c | — | 17.7Mindirect | Sep 26, 2023 | Sep 28, 2023 | Form 4 ↗ |
| BIOGEN INC.10% owner | Sale | −100.0K | $5.27 | $527K | 23.7Mindirect | Aug 30, 2022 | Aug 31, 2022 | Form 4 ↗ |
| BIOGEN INC.10% owner | Sale | −400.0K | $5.33 | $2.1M | 23.8Mindirect | Aug 29, 2022 | Aug 31, 2022 | Form 4 ↗ |
| Markels JohnDirector | Purchase | +6,784 | $3.69 | $25K | 32.5Kdirect | Jun 3, 2022 | Jun 6, 2022 | Form 4 ↗ |
| PARKER H STEWARTDirector | Purchase | +5,000 | $3.60 | $18K | 48.7Kdirect | Jun 1, 2022 | Jun 3, 2022 | Form 4 ↗ |
| BIOGEN INC.10% owner | Sale | −2,764 | $8.51 | $24K | 24.2Mindirect | Dec 28, 2021 | Dec 30, 2021 | Form 4 ↗ |
| BIOGEN INC.10% owner | Sale | −600 | $8.56 | $5K | 24.2Mindirect | Dec 27, 2021 | Dec 28, 2021 | Form 4 ↗ |
| BIOGEN INC.10% owner | Sale | −81.2K | $8.55 | $694K | 24.2Mindirect | Dec 23, 2021 | Dec 28, 2021 | Form 4 ↗ |
| BIOGEN INC.10% owner | Sale | −23.7K | $8.56 | $203K | 24.2Mindirect | Dec 9, 2021 | Dec 10, 2021 | Form 4 ↗ |
| BIOGEN INC.10% owner | Sale | −75.8K | $8.64 | $655K | 24.3Mindirect | Dec 8, 2021 | Dec 9, 2021 | Form 4 ↗ |
| BIOGEN INC.10% owner | Sale | −52.2K | $8.52 | $445K | 24.3Mindirect | Dec 7, 2021 | Dec 9, 2021 | Form 4 ↗ |
| Biogen MA Inc.10% owner | Sale | −1,874 | $8.51 | $16K | 24.4Mindirect | Dec 2, 2021 | Dec 3, 2021 | Form 4 ↗ |
| Biogen MA Inc.10% owner | Sale | −730 | $8.52 | $6K | 24.4Mindirect | Dec 1, 2021 | Dec 3, 2021 | Form 4 ↗ |
| Biogen MA Inc.10% owner | Sale | −28.9K | $8.60 | $248K | 24.4Mindirect | Nov 26, 2021 | Nov 30, 2021 | Form 4 ↗ |
| LOEB GARYEVP, General Counsel & Sec. | Sale | −543 | $13.17 | $7K | 83.2Kdirect | Mar 23, 2021 | Mar 25, 2021 | Form 4 ↗ |
| LOEB GARYEVP, General Counsel & Sec. | Sale | −5,000 | $13.18 | $66K | 83.8Kdirect | Mar 23, 2021 | Mar 25, 2021 | Form 4 ↗ |
| LOEB GARYEVP, General Counsel & Sec. | Sale | −12.0K | $13.10 | $157K | 88.8Kdirect | Mar 23, 2021 | Mar 25, 2021 | Form 4 ↗ |
| Ramelmeier Rolf AndrewEVP, Technical Operations | Sale | −2,464 | $16.74 | $41K | 66.0Kdirect | Dec 31, 2020 | Jan 6, 2021 | Form 4 ↗ |
| Ramelmeier Rolf AndrewEVP, Technical Operations | Sale | −3,331 | $18.13 | $60K | 68.4Kdirect | Dec 24, 2020 | Dec 30, 2020 | Form 4 ↗ |
| Ramasastry SairaDirector | Sale | −10.0K | $13.27 | $133K | 15.0Kdirect | Dec 17, 2020 | Dec 18, 2020 | Form 4 ↗ |
| DILLY STEPHEN GEORGEDirector | Sale | −35.0K | $6.00 | $210K | 5,000direct | Mar 19, 2020 | Mar 20, 2020 | Form 4 ↗ |
| PARKER H STEWARTDirector | Purchase | +3,000 | $5.20 | $16K | 13.0Kdirect | Mar 18, 2020 | Mar 19, 2020 | Form 4 ↗ |
| Zakrzewski Joseph SDirector | Purchase | +5,000 | $4.99 | $25K | 30.0Kdirect | Mar 17, 2020 | Mar 19, 2020 | Form 4 ↗ |
| DILLY STEPHEN GEORGEDirector | Sale | −15.0K | $6.02 | $90K | 5,000direct | Mar 16, 2020 | Mar 18, 2020 | Form 4 ↗ |
| Zakrzewski Joseph SDirector | Purchase | +5,000 | $5.67 | $28K | 25.0Kdirect | Mar 13, 2020 | Mar 13, 2020 | Form 4 ↗ |
| Zakrzewski Joseph SDirector | Purchase | +15.0K | $6.31 | $95K | 20.0Kdirect | Mar 12, 2020 | Mar 13, 2020 | Form 4 ↗ |
| Yi KathyEVP & Chief Financial Officer | Sale | −5,000 | $10.00 | $50K | 25.5Kdirect | May 15, 2019 | May 17, 2019 | Form 4 ↗ |
| Yi KathyEVP & Chief Financial Officer | Sale | −5,000 | $12.11 | $61K | 25.5Kdirect | Apr 15, 2019 | Apr 16, 2019 | Form 4 ↗ |
| Yi KathyEVP & Chief Financial Officer | Sale | −5,000 | $10.00 | $50K | 25.5Kdirect | Mar 15, 2019 | Mar 18, 2019 | Form 4 ↗ |
| Yi KathyEVP & Chief Financial Officer | Sale | −5,000 | $10.00 | $50K | 25.5Kdirect | Mar 1, 2019 | Mar 5, 2019 | Form 4 ↗ |
| Yi KathySVP & Chief Financial Officer | Sale | −5,000 | $11.04 | $55K | 7,250direct | Jan 15, 2019 | Jan 16, 2019 | Form 4 ↗ |
| Conner Edward R.Sr. VP & Chief Medical Officer | Sale | −5,000 | $12.33 | $62K | 12.1Kdirect | Jan 7, 2019 | Jan 8, 2019 | Form 4 ↗ |
| Yi KathySVP & Chief Financial Officer | Sale | −5,000 | $11.44 | $57K | 7,250direct | Dec 17, 2018 | Dec 18, 2018 | Form 4 ↗ |
| Conner Edward R.Sr. VP & Chief Medical Officer | Sale | −5,000 | $11.49 | $57K | 12.1Kdirect | Dec 6, 2018 | Dec 7, 2018 | Form 4 ↗ |
| Yi KathySVP & Chief Financial Officer | Sale | −5,000 | $10.00 | $50K | 7,250direct | Nov 15, 2018 | Nov 16, 2018 | Form 4 ↗ |
| PARKER H STEWARTDirector | Purchase | +2,000 | $9.00 | $18K | 7,500direct | Nov 14, 2018 | Nov 15, 2018 | Form 4 ↗ |
| Conner Edward R.Sr. VP & Chief Medical Officer | Sale | −5,000 | $13.73 | $69K | 12.1Kdirect | Nov 6, 2018 | Nov 7, 2018 | Form 4 ↗ |
| Yi KathySVP & Chief Financial Officer | Sale | −5,000 | $13.97 | $70K | 7,250direct | Oct 15, 2018 | Oct 16, 2018 | Form 4 ↗ |
| Conner Edward R.Sr. VP & Chief Medical Officer | Sale | −5,000 | $14.55 | $73K | 10.1Kdirect | Oct 8, 2018 | Oct 9, 2018 | Form 4 ↗ |
| Yi KathySVP & Chief Financial Officer | Sale | −5,000 | $14.66 | $73K | 7,250direct | Sep 17, 2018 | Sep 18, 2018 | Form 4 ↗ |
| JEFFS ROGERDirector | Purchase | +7,408 | $13.56 | $100K | 9,908direct | Sep 7, 2018 | Sep 7, 2018 | Form 4 ↗ |
| PARKER H STEWARTDirector | Purchase | +2,000 | $13.52 | $27K | 5,500direct | Sep 7, 2018 | Sep 7, 2018 | Form 4 ↗ |
| Conner Edward R.Sr. VP & Chief Medical Officer | Sale | −5,000 | $14.17 | $71K | 10.1Kdirect | Sep 6, 2018 | Sep 7, 2018 | Form 4 ↗ |
| Yi KathySVP & Chief Financial Officer | Sale | −5,000 | $15.39 | $77K | 7,250direct | Aug 16, 2018 | Aug 17, 2018 | Form 4 ↗ |
| Conner Edward R.Sr. VP & Chief Medical Officer | Sale | −5,000 | $13.45 | $67K | 10.1Kdirect | Aug 6, 2018 | Aug 7, 2018 | Form 4 ↗ |
| Yi KathySVP & Chief Financial Officer | Sale | −5,000 | $14.77 | $74K | 7,250direct | Jul 16, 2018 | Jul 17, 2018 | Form 4 ↗ |
| Conner Edward R.Sr. VP & Chief Medical Officer | Sale | −5,000 | $15.80 | $79K | 10.1Kdirect | Jul 6, 2018 | Jul 9, 2018 | Form 4 ↗ |
| Yi KathySVP & Chief Financial Officer | Sale | −5,000 | $15.67 | $78K | 7,250direct | Jun 15, 2018 | Jun 15, 2018 | Form 4 ↗ |
| Conner Edward R.Sr. VP & Chief Medical Officer | Sale | −5,000 | $16.67 | $83K | 10.1Kdirect | Jun 6, 2018 | Jun 7, 2018 | Form 4 ↗ |
| Yi KathySVP & Chief Financial Officer | Sale | −5,000 | $15.38 | $77K | 7,250direct | May 15, 2018 | May 16, 2018 | Form 4 ↗ |
| Conner Edward R.Sr. VP & Chief Medical Officer | Sale | −5,000 | $16.36 | $82K | 10.1Kdirect | May 7, 2018 | May 9, 2018 | Form 4 ↗ |
| Yi KathySVP & Chief Financial Officer | Sale | −5,000 | $19.83 | $99K | 7,250direct | Apr 16, 2018 | Apr 18, 2018 | Form 4 ↗ |
| Herberts Curt A. IIISr.VP & Chief Business Officer | Sale | −8,163 | $20.00 | $163K | 14.6Kdirect | Apr 13, 2018 | Apr 17, 2018 | Form 4 ↗ |
| Conner Edward R.Sr. VP & Chief Medical Officer | Sale | −5,000 | $17.41 | $87K | 8,125direct | Apr 6, 2018 | Apr 9, 2018 | Form 4 ↗ |
| Mento Steven JDirector | Sale | −100 | $18.90 | $2K | 11.8Kdirect | Apr 2, 2018 | Apr 4, 2018 | Form 4 ↗ |
| Mento Steven JDirector | Sale | −7,115 | $18.39 | $131K | 11.9Kdirect | Apr 2, 2018 | Apr 4, 2018 | Form 4 ↗ |
| Herberts Curt A. IIISr.VP & Chief Business Officer | Sale | −2,278 | $18.30 | $42K | 14.6Kdirect | Apr 2, 2018 | Apr 4, 2018 | Form 4 ↗ |
| Yi KathySVP & Chief Financial Officer | Sale | −5,000 | $25.56 | $128K | 7,250direct | Mar 15, 2018 | Mar 16, 2018 | Form 4 ↗ |
| Conner Edward R.Sr. VP & Chief Medical Officer | Sale | −5,000 | $24.78 | $124K | 8,125direct | Mar 6, 2018 | Mar 7, 2018 | Form 4 ↗ |
| Mento Steven JDirector | Sale | −9,433 | $23.27 | $220K | 9,047direct | Mar 1, 2018 | Mar 5, 2018 | Form 4 ↗ |
| Herberts Curt A. IIISr.VP & Chief Business Officer | Sale | −15.0K | $23.06 | $346K | 14.6Kdirect | Mar 1, 2018 | Mar 5, 2018 | Form 4 ↗ |
| Ramasastry SairaDirector | Sale | −9,450 | $24.88 | $235K | 0direct | Feb 26, 2018 | Feb 27, 2018 | Form 4 ↗ |
| Conner Edward R.Sr. VP & Chief Medical Officer | Sale | −5,000 | $18.49 | $92K | 8,125direct | Feb 6, 2018 | Feb 7, 2018 | Form 4 ↗ |
| Mento Steven JDirector | Sale | −11.5K | $20.59 | $237K | 3,480direct | Feb 1, 2018 | Feb 5, 2018 | Form 4 ↗ |
| Herberts Curt A. IIISr.VP & Chief Business Officer | Sale | −15.0K | $20.59 | $309K | 14.6Kdirect | Feb 1, 2018 | Feb 5, 2018 | Form 4 ↗ |
| Conner Edward R.Sr. VP & Chief Medical Officer | Sale | −5,000 | $17.11 | $86K | 2,000direct | Jan 8, 2018 | Jan 10, 2018 | Form 4 ↗ |
| Herberts Curt A. IIISr.VP & Chief Business Officer | Sale | −8,026 | $18.05 | $145K | 6,250direct | Jan 3, 2018 | Jan 4, 2018 | Form 4 ↗ |
| Herberts Curt A. IIISr.VP & Chief Business Officer | Sale | −6,974 | $16.35 | $114K | 6,250direct | Jan 2, 2018 | Jan 4, 2018 | Form 4 ↗ |
| Conner Edward R.Sr. VP & Chief Medical Officer | Sale | −5,000 | $16.24 | $81K | 0direct | Dec 6, 2017 | Dec 8, 2017 | Form 4 ↗ |
| Herberts Curt A. IIISr.VP & Chief Business Officer | Sale | −11.8K | $18.00 | $212K | 15.8Kdirect | Dec 4, 2017 | Dec 6, 2017 | Form 4 ↗ |
| Herberts Curt A. IIISr.VP & Chief Business Officer | Sale Amended | −3,197 | $16.70 | $53K | 15.8Kdirect | Dec 1, 2017 | Dec 4, 2017 | Form 4 ↗ |
| Herberts Curt A. IIISr.VP & Chief Business Officer | Sale | −3,197 | $16.70 | $53K | 15.8Kdirect | Dec 1, 2017 | Dec 4, 2017 | Form 4 ↗ |
| Herberts Curt A. IIISr.VP & Chief Business Officer | Sale Amended | −13.4K | $16.00 | $215K | 17.8Kdirect | Nov 30, 2017 | Dec 4, 2017 | Form 4 ↗ |
| Herberts Curt A. IIISr.VP & Chief Business Officer | Sale | −13.4K | $16.00 | $215K | 17.8Kdirect | Nov 30, 2017 | Dec 4, 2017 | Form 4 ↗ |
| Ramasastry SairaDirector | Sale | −5,000 | $14.67 | $73K | 0direct | Nov 17, 2017 | Nov 21, 2017 | Form 4 ↗ |
| Herberts Curt A. IIISr.VP & Chief Business Officer | Sale | −3,754 | $16.00 | $60K | 15.8Kdirect | Oct 2, 2017 | Oct 4, 2017 | Form 4 ↗ |
| Herberts Curt A. IIISr.VP & Chief Business Officer | Sale | −5,416 | $15.00 | $81K | 15.8Kdirect | Oct 2, 2017 | Oct 4, 2017 | Form 4 ↗ |
| Herberts Curt A. IIISr.VP & Chief Business Officer | Sale | −5,830 | $15.00 | $87K | 15.8Kdirect | Oct 2, 2017 | Oct 4, 2017 | Form 4 ↗ |
| RINGO WILLIAM RDirector | Sale | −31.0K | $14.37 | $445K | 800direct | Sep 20, 2017 | Sep 22, 2017 | Form 4 ↗ |
| Herberts Curt A. IIISr.VP & Chief Business Officer | Sale | −10.3K | $15.00 | $155K | 15.8Kdirect | Sep 1, 2017 | Sep 1, 2017 | Form 4 ↗ |
| Herberts Curt A. IIISr.VP & Chief Business Officer | Sale | −4,684 | $15.00 | $70K | 15.8Kdirect | Sep 1, 2017 | Sep 1, 2017 | Form 4 ↗ |
| Herberts Curt A. IIISr.VP & Chief Business Officer | Sale | −5,000 | $11.00 | $55K | 20.5Kdirect | Aug 14, 2017 | Aug 15, 2017 | Form 4 ↗ |
| Herberts Curt A. IIISr.VP & Chief Business Officer | Sale | −6,474 | $10.00 | $65K | 20.5Kdirect | Aug 11, 2017 | Aug 15, 2017 | Form 4 ↗ |
| Herberts Curt A. IIISr.VP & Chief Business Officer | Sale | −14.8K | $10.00 | $148K | 20.5Kdirect | Jul 14, 2017 | Jul 14, 2017 | Form 4 ↗ |
| Herberts Curt A. IIISr.VP & Chief Business Officer | Sale | −172 | $10.00 | $2K | 35.3Kdirect | Jul 14, 2017 | Jul 14, 2017 | Form 4 ↗ |
| Herberts Curt A. IIISenior VP & CBO | Sale | −2,000 | $6.80 | $14K | 35.3Kdirect | Jun 1, 2017 | Jun 2, 2017 | Form 4 ↗ |
| Herberts Curt A. IIISenior VP & CBO | Sale | −2,000 | $8.50 | $17K | 37.3Kdirect | May 12, 2017 | May 15, 2017 | Form 4 ↗ |
| Herberts Curt A. IIISenior VP & CBO | Sale | −639 | $6.50 | $4K | 39.3Kdirect | May 11, 2017 | May 15, 2017 | Form 4 ↗ |
| LANPHIER EDWARD O IIPresident & CEO · Director | Sale | −25.0K | $10.43 | $261K | 235.0Kdirect | Jul 15, 2015 | Jul 17, 2015 | Form 4 ↗ |
| Wolff Henry WardExec VP & CFO | Sale | −2,000 | $10.00 | $20K | 197.9Kdirect | Jul 13, 2015 | Jul 14, 2015 | Form 4 ↗ |
| Wolff Henry WardExec VP & CFO | Sale | −3,898 | $10.00 | $39K | 199.9Kdirect | Jul 13, 2015 | Jul 14, 2015 | Form 4 ↗ |
| Wolff Henry WardExec VP & CFO | Sale | −6,102 | $10.00 | $61K | 199.9Kdirect | Jul 10, 2015 | Jul 14, 2015 | Form 4 ↗ |
| LANPHIER EDWARD O IIPresident & CEO · Director | Sale | −25.0K | $11.08 | $277K | 235.0Kdirect | Jun 15, 2015 | Jun 17, 2015 | Form 4 ↗ |
| Wolff Henry WardExec VP & CFO | Sale | −2,000 | $12.21 | $24K | 199.9Kdirect | Jun 10, 2015 | Jun 12, 2015 | Form 4 ↗ |
| Wolff Henry WardExec VP & CFO | Sale | −10.0K | $12.21 | $122K | 201.9Kdirect | Jun 10, 2015 | Jun 12, 2015 | Form 4 ↗ |
| ANDO DALE GVP, Therapeutic Dev. & CMO | Sale | −15.0K | $12.29 | $184K | 96.8Kdirect | Jun 5, 2015 | Jun 9, 2015 | Form 4 ↗ |
| RINGO WILLIAM RDirector | Sale | −2,200 | $12.44 | $27K | 800direct | Jun 3, 2015 | Jun 3, 2015 | Form 4 ↗ |
| Gregory Philip DSVP of Research & CSO | Sale | −15.0K | $12.39 | $186K | 116.4Kdirect | Jun 1, 2015 | Jun 3, 2015 | Form 4 ↗ |
| LANPHIER EDWARD O IIPresident & CEO · Director | Sale | −25.0K | $11.51 | $288K | 235.0Kdirect | May 15, 2015 | May 19, 2015 | Form 4 ↗ |
| Wolff Henry WardExec VP & CFO | Sale | −2,000 | $13.25 | $27K | 201.9Kdirect | May 11, 2015 | May 13, 2015 | Form 4 ↗ |
| Wolff Henry WardExec VP & CFO | Sale | −10.0K | $13.25 | $133K | 203.9Kdirect | May 11, 2015 | May 13, 2015 | Form 4 ↗ |
| ANDO DALE GVP, Therapeutic Dev. & CMO | Sale | −15.0K | $12.29 | $184K | 95.4Kdirect | May 5, 2015 | May 5, 2015 | Form 4 ↗ |
| RINGO WILLIAM RDirector | Sale | −3,000 | $12.98 | $39K | 800direct | May 4, 2015 | May 5, 2015 | Form 4 ↗ |
| Gregory Philip DSVP of Research & CSO | Sale | −15.0K | $12.62 | $189K | 116.4Kdirect | May 1, 2015 | May 5, 2015 | Form 4 ↗ |
| LANPHIER EDWARD O IIPresident & CEO · Director | Sale | −25.0K | $15.33 | $383K | 235.0Kdirect | Apr 15, 2015 | Apr 17, 2015 | Form 4 ↗ |
| Wolff Henry WardExec VP & CFO | Sale | −1,029 | $15.37 | $16K | 202.8Kdirect | Apr 10, 2015 | Apr 14, 2015 | Form 4 ↗ |
| Wolff Henry WardExec VP & CFO | Sale | −971 | $15.43 | $15K | 203.9Kdirect | Apr 10, 2015 | Apr 14, 2015 | Form 4 ↗ |
| Wolff Henry WardExec VP & CFO | Sale | −10.0K | $15.30 | $153K | 204.8Kdirect | Apr 10, 2015 | Apr 14, 2015 | Form 4 ↗ |
| ANDO DALE GVP, Therapeutic Dev. & CMO | Sale | −15.0K | $14.94 | $224K | 95.4Kdirect | Apr 6, 2015 | Apr 8, 2015 | Form 4 ↗ |
| RINGO WILLIAM RDirector | Sale | −2,200 | $14.95 | $33K | 800direct | Apr 6, 2015 | Apr 8, 2015 | Form 4 ↗ |
| Gregory Philip DSVP of Research & CSO | Sale | −15.0K | $15.15 | $227K | 116.4Kdirect | Apr 1, 2015 | Apr 3, 2015 | Form 4 ↗ |
| Wolff Henry WardExec VP & CFO | Sale | −10.0K | $18.00 | $180K | 204.8Kdirect | Mar 19, 2015 | Mar 20, 2015 | Form 4 ↗ |
| LANPHIER EDWARD O IIPresident & CEO · Director | Sale | −25.0K | $17.29 | $432K | 235.0Kdirect | Mar 16, 2015 | Mar 18, 2015 | Form 4 ↗ |
| Wolff Henry WardExec VP & CFO | Sale | −2,000 | $16.68 | $33K | 204.8Kdirect | Mar 10, 2015 | Mar 12, 2015 | Form 4 ↗ |
| Wolff Henry WardExec VP & CFO | Sale | −10.0K | $16.68 | $167K | 206.8Kdirect | Mar 10, 2015 | Mar 12, 2015 | Form 4 ↗ |
| Mento Steven JDirector | Sale | −6,501 | $18.30 | $119K | 12.3Kdirect | Mar 5, 2015 | Mar 6, 2015 | Form 4 ↗ |
| ANDO DALE GVP, Therapeutic Dev. & CMO | Sale | −15.0K | $18.29 | $274K | 95.4Kdirect | Mar 5, 2015 | Mar 6, 2015 | Form 4 ↗ |
| Wolff Henry WardExec VP & CFO | Sale | −10.0K | $18.00 | $180K | 206.8Kdirect | Mar 4, 2015 | Mar 6, 2015 | Form 4 ↗ |
| RINGO WILLIAM RDirector | Sale | −2,200 | $17.21 | $38K | 800direct | Mar 3, 2015 | Mar 4, 2015 | Form 4 ↗ |
| Gregory Philip DSVP of Research & CSO | Sale | −15.0K | $17.26 | $259K | 116.4Kdirect | Mar 2, 2015 | Mar 4, 2015 | Form 4 ↗ |
| LANPHIER EDWARD O IIPresident & CEO · Director | Sale | −25.0K | $15.69 | $392K | 235.0Kdirect | Feb 17, 2015 | Feb 19, 2015 | Form 4 ↗ |
| Ramasastry SairaDirector | Sale | −10.0K | $15.00 | $150K | 0direct | Feb 12, 2015 | Feb 13, 2015 | Form 4 ↗ |
| Wolff Henry WardExec VP & CFO | Sale | −1,029 | $12.65 | $13K | 206.8Kdirect | Feb 10, 2015 | Feb 12, 2015 | Form 4 ↗ |
| Wolff Henry WardExec VP & CFO | Sale | −971 | $12.63 | $12K | 207.9Kdirect | Feb 10, 2015 | Feb 12, 2015 | Form 4 ↗ |
| Wolff Henry WardExec VP & CFO | Sale | −10.0K | $12.65 | $127K | 208.8Kdirect | Feb 10, 2015 | Feb 12, 2015 | Form 4 ↗ |
| ANDO DALE GVP, Therapeutic Dev. & CMO | Sale | −15.0K | $12.93 | $194K | 95.4Kdirect | Feb 5, 2015 | Feb 6, 2015 | Form 4 ↗ |
| RINGO WILLIAM RDirector | Sale | −2,200 | $12.70 | $28K | 800direct | Feb 3, 2015 | Feb 5, 2015 | Form 4 ↗ |
| Gregory Philip DSVP of Research & CSO | Sale | −15.0K | $12.86 | $193K | 116.4Kdirect | Feb 2, 2015 | Feb 4, 2015 | Form 4 ↗ |
| LANPHIER EDWARD O IIPresident & CEO · Director | Sale | −10.0K | $14.29 | $143K | 235.0Kdirect | Jan 16, 2015 | Jan 16, 2015 | Form 4 ↗ |
| LANPHIER EDWARD O IIPresident & CEO · Director | Sale | −1,600 | $14.97 | $24K | 235.0Kdirect | Jan 15, 2015 | Jan 16, 2015 | Form 4 ↗ |
| LANPHIER EDWARD O IIPresident & CEO · Director | Sale | −13.4K | $14.09 | $189K | 236.6Kdirect | Jan 15, 2015 | Jan 16, 2015 | Form 4 ↗ |
| Wolff Henry WardExec VP & CFO | Sale | −2,000 | $15.87 | $32K | 208.8Kdirect | Jan 12, 2015 | Jan 14, 2015 | Form 4 ↗ |
| Wolff Henry WardExec VP & CFO | Sale | −10.0K | $15.87 | $159K | 210.8Kdirect | Jan 12, 2015 | Jan 14, 2015 | Form 4 ↗ |
| RINGO WILLIAM RDirector | Sale | −2,200 | $15.20 | $33K | 800direct | Jan 5, 2015 | Jan 6, 2015 | Form 4 ↗ |
| LARSON JOHN WILLIAMDirector | Sale | −15.0K | $15.10 | $227K | 214.7Kdirect | Jan 5, 2015 | Jan 6, 2015 | Form 4 ↗ |
| ANDO DALE GVP, Therapeutic Dev. & CMO | Sale | −600 | $15.66 | $9K | 95.4Kdirect | Jan 5, 2015 | Jan 6, 2015 | Form 4 ↗ |
| ANDO DALE GVP, Therapeutic Dev. & CMO | Sale | −14.4K | $15.17 | $218K | 96.0Kdirect | Jan 5, 2015 | Jan 6, 2015 | Form 4 ↗ |
| Gregory Philip DSVP, Research & CSO | Sale | −15.0K | $15.78 | $237K | 116.4Kdirect | Jan 2, 2015 | Jan 6, 2015 | Form 4 ↗ |
| LANPHIER EDWARD O IIPresident & CEO · Director | Sale | −16.0K | $14.79 | $237K | 323.5Kdirect | Dec 15, 2014 | Dec 15, 2014 | Form 4 ↗ |
| LANPHIER EDWARD O IIPresident & CEO · Director | Sale | −9,000 | $16.47 | $148K | 339.5Kdirect | Dec 15, 2014 | Dec 15, 2014 | Form 4 ↗ |
| LARSON JOHN WILLIAMDirector | Sale | −10.0K | $16.28 | $163K | 214.7Kdirect | Dec 15, 2014 | Dec 15, 2014 | Form 4 ↗ |
| Mento Steven JDirector | Sale | −6,354 | $15.00 | $95K | 28.7Kdirect | Dec 11, 2014 | Dec 15, 2014 | Form 4 ↗ |
| LARSON JOHN WILLIAMDirector | Sale | −10.0K | $12.00 | $120K | 214.7Kdirect | Dec 9, 2014 | Dec 9, 2014 | Form 4 ↗ |
| ANDO DALE GVP, Therapeutic Dev. & CMO | Sale | −15.0K | $11.21 | $168K | 97.9Kdirect | Dec 5, 2014 | Dec 9, 2014 | Form 4 ↗ |
| Gregory Philip DSVP of Research & CSO | Sale | −15.0K | $11.68 | $175K | 109.3Kdirect | Dec 1, 2014 | Dec 3, 2014 | Form 4 ↗ |
| LANPHIER EDWARD O IIPresident & CEO · Director | Sale | −25.0K | $11.23 | $281K | 295.0Kdirect | Nov 17, 2014 | Nov 19, 2014 | Form 4 ↗ |
| LARSON JOHN WILLIAMDirector | Sale | −10.0K | $12.00 | $120K | 214.7Kdirect | Nov 12, 2014 | Nov 13, 2014 | Form 4 ↗ |
| Wolff Henry WardExec VP & CFO | Sale | −2,000 | $11.37 | $23K | 213.4Kdirect | Nov 10, 2014 | Nov 13, 2014 | Form 4 ↗ |
| ANDO DALE GVP, Therapeutic Dev. & CMO | Sale | −15.0K | $11.35 | $170K | 97.9Kdirect | Nov 5, 2014 | Nov 7, 2014 | Form 4 ↗ |
| Gregory Philip DSVP of Research & CSO | Sale | −15.0K | $11.91 | $179K | 109.3Kdirect | Nov 3, 2014 | Nov 5, 2014 | Form 4 ↗ |
| LARSON JOHN WILLIAMDirector | Sale | −10.0K | $12.02 | $120K | 214.7Kdirect | Oct 28, 2014 | Oct 30, 2014 | Form 4 ↗ |
| LANPHIER EDWARD O IIPresident & CEO · Director | Sale | −25.0K | $10.49 | $262K | 295.0Kdirect | Oct 15, 2014 | Oct 17, 2014 | Form 4 ↗ |
| Wolff Henry WardExec VP & CFO | Sale | −2,000 | $10.10 | $20K | 214.3Kdirect | Oct 10, 2014 | Oct 14, 2014 | Form 4 ↗ |
| ANDO DALE GVP, Therapeutic Dev. & CMO | Sale | −15.0K | $10.72 | $161K | 96.6Kdirect | Oct 6, 2014 | Oct 8, 2014 | Form 4 ↗ |
| Gregory Philip DSVP of Research & CSO | Sale | −15.0K | $10.80 | $162K | 109.3Kdirect | Oct 1, 2014 | Oct 3, 2014 | Form 4 ↗ |
| LANPHIER EDWARD O IIPresident & CEO · Director | Sale | −25.0K | $12.14 | $304K | 295.0Kdirect | Sep 15, 2014 | Sep 17, 2014 | Form 4 ↗ |
| Wolff Henry WardExec VP & CFO | Sale | −2,000 | $12.31 | $25K | 216.3Kdirect | Sep 10, 2014 | Sep 12, 2014 | Form 4 ↗ |
| ANDO DALE GVP, Therapeutic Dev. & CMO | Sale | −15.0K | $12.20 | $183K | 96.6Kdirect | Sep 5, 2014 | Sep 5, 2014 | Form 4 ↗ |
| LARSON JOHN WILLIAMDirector | Sale | −10.0K | $12.81 | $128K | 218.2Kdirect | Sep 4, 2014 | Sep 5, 2014 | Form 4 ↗ |
| Gregory Philip DSVP of Research & CSO | Sale | −15.0K | $13.45 | $202K | 109.3Kdirect | Sep 2, 2014 | Sep 4, 2014 | Form 4 ↗ |
| LANPHIER EDWARD O IIPresident & CEO · Director | Sale | −25.0K | $13.95 | $349K | 295.0Kdirect | Aug 15, 2014 | Aug 15, 2014 | Form 4 ↗ |
| Wolff Henry WardExec VP & CFO | Sale | −2,000 | $14.14 | $28K | 218.3Kdirect | Aug 11, 2014 | Aug 12, 2014 | Form 4 ↗ |
| Wolff Henry WardExec VP & CFO | Sale | −8,000 | $14.17 | $113K | 220.3Kdirect | Aug 11, 2014 | Aug 12, 2014 | Form 4 ↗ |
| Ramasastry SairaDirector | Sale | −10.0K | $14.00 | $140K | 0direct | Aug 8, 2014 | Aug 12, 2014 | Form 4 ↗ |
| ANDO DALE GVP, Therapeutic Dev. & CMO | Sale | −1,798 | $12.98 | $23K | 96.6Kdirect | Aug 5, 2014 | Aug 5, 2014 | Form 4 ↗ |
| ANDO DALE GVP, Therapeutic Dev. & CMO | Sale | −13.2K | $12.99 | $171K | 98.4Kdirect | Aug 5, 2014 | Aug 5, 2014 | Form 4 ↗ |
| LARSON JOHN WILLIAMDirector | Sale | −10.0K | $12.56 | $126K | 218.2Kdirect | Aug 4, 2014 | Aug 5, 2014 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −27.8K | $12.82 | $356K | 1.8Mdirect | Aug 1, 2014 | Feb 18, 2015 | Form 4 ↗ |
| Gregory Philip DSVP of Research & CSO | Sale | −15.0K | $12.54 | $188K | 109.3Kdirect | Aug 1, 2014 | Aug 5, 2014 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −31.1K | $12.59 | $392K | 1.9Mdirect | Jul 30, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −57.9K | $12.36 | $716K | 1.9Mdirect | Jul 30, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −20.6K | $12.35 | $254K | 1.9Mdirect | Jul 30, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −1,407 | $12.41 | $17K | 2.0Mdirect | Jul 29, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −35.3K | $12.11 | $427K | 2.0Mdirect | Jul 28, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −24.8K | $12.10 | $300K | 2.0Mdirect | Jul 28, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −47.4K | $12.31 | $584K | 2.0Mdirect | Jul 25, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −124.0K | $12.28 | $1.5M | 2.1Mdirect | Jul 24, 2014 | Feb 18, 2015 | Form 4 ↗ |
| LANPHIER EDWARD O IIPresident & CEO · Director | Sale | −25.0K | $12.16 | $304K | 295.0Kdirect | Jul 18, 2014 | Jul 18, 2014 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Purchase | +37.2K | $12.26 | $456K | 2.2Mdirect | Jul 17, 2014 | Feb 18, 2015 | Form 4 ↗ |
| Wolff Henry WardExec VP & CFO | Sale | −2,000 | $13.19 | $26K | 220.3Kdirect | Jul 10, 2014 | Jul 11, 2014 | Form 4 ↗ |
| Wolff Henry WardExec VP & CFO | Sale | −13.0K | $13.27 | $173K | 222.3Kdirect | Jul 10, 2014 | Jul 11, 2014 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −49.6K | $16.05 | $796K | 2.2Mdirect | Jul 1, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −33.1K | $15.96 | $528K | 2.2Mdirect | Jul 1, 2014 | Feb 18, 2015 | Form 4 ↗ |
| Gregory Philip DSVP of Research & CSO | Sale | −15.0K | $15.66 | $235K | 109.3Kdirect | Jul 1, 2014 | Jul 3, 2014 | Form 4 ↗ |
| Ramasastry SairaDirector | Sale | −5,550 | $15.53 | $86K | 0direct | Jun 23, 2014 | Jun 25, 2014 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −107.8K | $16.60 | $1.8M | 2.2Mdirect | Jun 16, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −137.2K | $16.52 | $2.3M | 2.4Mdirect | Jun 16, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −3,695 | $16.52 | $61K | 2.5Mdirect | Jun 16, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −1,838 | $16.35 | $30K | 2.5Mdirect | Jun 16, 2014 | Feb 18, 2015 | Form 4 ↗ |
| LANPHIER EDWARD O IIPresident & CEO · Director | Sale | −25.0K | $16.41 | $410K | 1.5Mindirect | Jun 16, 2014 | Jun 18, 2014 | Form 4 ↗ |
| Wolff Henry WardExec VP & CFO | Sale | −2,000 | $15.63 | $31K | 222.3Kdirect | Jun 10, 2014 | Jun 11, 2014 | Form 4 ↗ |
| Wolff Henry WardExec VP & CFO | Sale | −13.0K | $15.62 | $203K | 224.3Kdirect | Jun 10, 2014 | Jun 11, 2014 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −22.5K | $15.50 | $349K | 2.5Mdirect | Jun 9, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −61.0K | $15.50 | $945K | 2.5Mdirect | Jun 9, 2014 | Feb 18, 2015 | Form 4 ↗ |
| Mento Steven JDirector | Sale | −4,328 | $15.00 | $65K | 25.1Kdirect | Jun 9, 2014 | Jun 11, 2014 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −83.5K | $14.40 | $1.2M | 2.6Mdirect | Jun 6, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −41.7K | $14.13 | $590K | 2.7Mdirect | Jun 6, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −9,852 | $14.07 | $139K | 2.7Mdirect | Jun 6, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −48.8K | $14.14 | $691K | 2.7Mdirect | Jun 5, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −66.3K | $14.13 | $936K | 2.8Mdirect | Jun 5, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −32.9K | $14.13 | $465K | 2.8Mdirect | Jun 5, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −18.4K | $13.98 | $257K | 2.9Mdirect | Jun 5, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −586 | $13.11 | $8K | 2.9Mdirect | Jun 5, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −918.5K | $13.00 | $11.9M | 2.9Mdirect | Jun 5, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −29.2K | $13.11 | $382K | 3.8Mdirect | Jun 4, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −20.8K | $13.11 | $273K | 3.8Mdirect | Jun 4, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −20.7K | $13.08 | $270K | 3.8Mdirect | Jun 4, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −76.8K | $12.86 | $988K | 3.9Mdirect | Jun 3, 2014 | Feb 18, 2015 | Form 4 ↗ |
| Gregory Philip DSVP of Research & CSO | Sale | −15.0K | $12.85 | $193K | 109.3Kdirect | Jun 2, 2014 | Jun 4, 2014 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −24.2K | $13.45 | $326K | 3.9Mdirect | May 30, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −41.7K | $13.38 | $557K | 4.0Mdirect | May 30, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −146.3K | $13.53 | $2.0M | 4.0Mdirect | May 29, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −9,390 | $13.51 | $127K | 4.2Mdirect | May 29, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −24.3K | $13.47 | $327K | 4.2Mdirect | May 28, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −124.4K | $13.42 | $1.7M | 4.2Mdirect | May 28, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −108.9K | $13.56 | $1.5M | 4.3Mdirect | May 27, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −154.6K | $13.55 | $2.1M | 4.4Mdirect | May 27, 2014 | Feb 18, 2015 | Form 4 ↗ |
| ANDO DALE GVP, Therapeutic Dev. & CMO | Sale | −2,000 | $13.57 | $27K | 98.4Kdirect | May 27, 2014 | May 29, 2014 | Form 4 ↗ |
| ANDO DALE GVP, Therapeutic Dev. & CMO | Sale | −13.0K | $13.57 | $176K | 98.4Kdirect | May 27, 2014 | May 29, 2014 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −51.6K | $13.27 | $685K | 4.6Mdirect | May 23, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −40.8K | $13.58 | $554K | 4.6Mdirect | May 22, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −15.6K | $13.51 | $210K | 4.7Mdirect | May 22, 2014 | Feb 18, 2015 | Form 4 ↗ |
| LANPHIER EDWARD O IIPresident & CEO · Director | Sale | −25.0K | $13.14 | $329K | 1.5Mindirect | May 15, 2014 | May 16, 2014 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −56.1K | $13.12 | $736K | 4.7Mdirect | May 13, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −10.3K | $13.06 | $134K | 4.7Mdirect | May 12, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −19.4K | $13.01 | $252K | 4.8Mdirect | May 12, 2014 | Feb 18, 2015 | Form 4 ↗ |
| Wolff Henry WardExec VP & CFO | Sale | −2,000 | $12.85 | $26K | 224.3Kdirect | May 12, 2014 | May 14, 2014 | Form 4 ↗ |
| Wolff Henry WardExec VP & CFO | Sale | −13.0K | $12.85 | $167K | 226.3Kdirect | May 12, 2014 | May 14, 2014 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −62.5K | $12.40 | $775K | 4.8Mdirect | May 8, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −20.8K | $12.39 | $258K | 4.8Mdirect | May 8, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Purchase | +35.7K | $12.09 | $432K | 4.9Mdirect | May 7, 2014 | Feb 18, 2015 | Form 4 ↗ |
| Kolchinsky Peter | Purchase | +40.6K | $11.74 | $476K | 4.8Mdirect | May 7, 2014 | Feb 18, 2015 | Form 4 ↗ |
| Kolchinsky Peter | Purchase | +6,998 | $11.71 | $82K | 4.8Mdirect | May 7, 2014 | Feb 18, 2015 | Form 4 ↗ |
| Gregory Philip DSVP of Research & CSO | Sale | −15.0K | $13.68 | $205K | 109.3Kdirect | May 1, 2014 | May 2, 2014 | Form 4 ↗ |
| Kolchinsky Peter | Purchase | +73.3K | $13.57 | $995K | 4.8Mdirect | Apr 30, 2014 | Feb 18, 2015 | Form 4 ↗ |
| Kolchinsky Peter | Purchase | +51.2K | $13.29 | $681K | 4.7Mdirect | Apr 30, 2014 | Feb 18, 2015 | Form 4 ↗ |
| Kolchinsky Peter | Purchase | +74.8K | $13.29 | $995K | 4.7Mdirect | Apr 28, 2014 | Feb 18, 2015 | Form 4 ↗ |
| ANDO DALE GVP, Therapeutic Dev. & CMO | Sale | +2,000 | $13.63 | $27K | 97.0Kdirect | Apr 28, 2014 | Apr 30, 2014 | Form 4 ↗ |
| ANDO DALE GVP, Therapeutic Dev. & CMO | Sale | +13.0K | $13.64 | $177K | 97.0Kdirect | Apr 28, 2014 | Apr 30, 2014 | Form 4 ↗ |
| LARSON JOHN WILLIAMDirector | Sale | −10.0K | $13.48 | $135K | 218.2Kdirect | Apr 28, 2014 | Apr 30, 2014 | Form 4 ↗ |
| Kolchinsky Peter | Purchase | +166.0K | $13.63 | $2.3M | 4.6Mdirect | Apr 25, 2014 | Feb 18, 2015 | Form 4 ↗ |
| Kolchinsky Peter | Sale | −41.5K | $15.02 | $623K | 4.4Mdirect | Apr 22, 2014 | Feb 18, 2015 | Form 4 ↗ |
| Kolchinsky Peter | Sale | −62.3K | $14.88 | $926K | 4.5Mdirect | Apr 22, 2014 | Feb 18, 2015 | Form 4 ↗ |
| Kolchinsky Peter | Sale | −166.0K | $14.86 | $2.5M | 4.5Mdirect | Apr 22, 2014 | Feb 18, 2015 | Form 4 ↗ |
| Kolchinsky Peter | Sale | −43.4K | $14.86 | $645K | 4.7Mdirect | Apr 22, 2014 | Feb 18, 2015 | Form 4 ↗ |
| Kolchinsky Peter | Sale | −39.6K | $14.70 | $582K | 4.7Mdirect | Apr 22, 2014 | Feb 18, 2015 | Form 4 ↗ |
| Kolchinsky Peter | Purchase | +41.5K | $14.02 | $582K | 4.8Mdirect | Apr 17, 2014 | Feb 18, 2015 | Form 4 ↗ |
| Kolchinsky Peter | Sale | −21.8K | $14.09 | $308K | 4.7Mdirect | Apr 16, 2014 | Feb 18, 2015 | Form 4 ↗ |
| Kolchinsky Peter | Purchase | +20.8K | $13.16 | $273K | 4.7Mdirect | Apr 15, 2014 | Feb 18, 2015 | Form 4 ↗ |
| Kolchinsky Peter | Purchase | +1,079 | $13.10 | $14K | 4.7Mdirect | Apr 15, 2014 | Feb 18, 2015 | Form 4 ↗ |
| LANPHIER EDWARD O IIPresident & CEO · Director | Sale | −25.0K | $14.20 | $355K | 1.6Mindirect | Apr 15, 2014 | Apr 17, 2014 | Form 4 ↗ |
| Kolchinsky Peter | Sale | −3,055 | $14.78 | $45K | 4.7Mdirect | Apr 14, 2014 | Feb 18, 2015 | Form 4 ↗ |
| Kolchinsky Peter | Purchase | +34.0K | $14.49 | $493K | 4.7Mdirect | Apr 11, 2014 | Feb 18, 2015 | Form 4 ↗ |
| Kolchinsky Peter | Purchase | +83.0K | $14.48 | $1.2M | 4.7Mdirect | Apr 11, 2014 | Feb 18, 2015 | Form 4 ↗ |
| Kolchinsky Peter | Sale | −3,403 | $15.67 | $53K | 4.6Mdirect | Apr 10, 2014 | Feb 18, 2015 | Form 4 ↗ |
| Kolchinsky Peter | Purchase | +83.0K | $14.91 | $1.2M | 4.6Mdirect | Apr 10, 2014 | Feb 18, 2015 | Form 4 ↗ |
| Wolff Henry WardExec VP & CFO | Sale | −2,000 | $15.74 | $31K | 225.3Kdirect | Apr 10, 2014 | Apr 11, 2014 | Form 4 ↗ |
| Wolff Henry WardExec VP & CFO | Sale | −13.0K | $15.72 | $204K | 227.3Kdirect | Apr 10, 2014 | Apr 11, 2014 | Form 4 ↗ |
| Kolchinsky Peter | Sale | −69.9K | $16.27 | $1.1M | 4.5Mdirect | Apr 9, 2014 | Feb 18, 2015 | Form 4 ↗ |
| Kolchinsky Peter | Purchase | +121.9K | $15.49 | $1.9M | 4.6Mdirect | Apr 8, 2014 | Feb 18, 2015 | Form 4 ↗ |
| Kolchinsky Peter | Purchase | +33.7K | $15.42 | $519K | 4.5Mdirect | Apr 7, 2014 | Feb 18, 2015 | Form 4 ↗ |
| Kolchinsky Peter | Purchase | +179.0K | $15.38 | $2.8M | 4.4Mdirect | Apr 4, 2014 | Feb 18, 2015 | Form 4 ↗ |
| Kolchinsky Peter | Purchase | +195.1K | $16.61 | $3.2M | 4.3Mdirect | Apr 3, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −75.1K | $18.14 | $1.4M | 4.1Mdirect | Apr 1, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −51.5K | $18.08 | $931K | 4.1Mdirect | Apr 1, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −50.0K | $17.95 | $898K | 4.2Mdirect | Apr 1, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −24.9K | $17.89 | $445K | 4.2Mdirect | Apr 1, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −48.5K | $17.88 | $867K | 4.3Mdirect | Apr 1, 2014 | Feb 18, 2015 | Form 4 ↗ |
| Gregory Philip DSr. VP Res. & CSO | Sale | −15.0K | $17.80 | $267K | 109.3Kdirect | Apr 1, 2014 | Apr 3, 2014 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Purchase | +62.2K | $17.11 | $1.1M | 4.3Mdirect | Mar 28, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Purchase | +21.8K | $17.07 | $373K | 4.3Mdirect | Mar 28, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Purchase | +252.0K | $17.66 | $4.5M | 4.2Mdirect | Mar 27, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Purchase | +4,200 | $17.35 | $73K | 4.0Mdirect | Mar 27, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Purchase | +190.7K | $18.16 | $3.5M | 4.0Mdirect | Mar 26, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Purchase | +19.3K | $17.88 | $345K | 3.8Mdirect | Mar 26, 2014 | Feb 18, 2015 | Form 4 ↗ |
| ANDO DALE GVP, Therapeutic Dev. & CMO | Sale | −2,000 | $18.64 | $37K | 97.0Kdirect | Mar 26, 2014 | Mar 28, 2014 | Form 4 ↗ |
| ANDO DALE GVP, Therapeutic Dev. & CMO | Sale | −200 | $19.10 | $4K | 97.0Kdirect | Mar 26, 2014 | Mar 28, 2014 | Form 4 ↗ |
| ANDO DALE GVP, Therapeutic Dev. & CMO | Sale | −12.8K | $18.64 | $239K | 97.2Kdirect | Mar 26, 2014 | Mar 28, 2014 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Purchase | +21.0K | $19.46 | $409K | 3.8Mdirect | Mar 25, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Purchase | +42.0K | $19.44 | $816K | 3.7Mdirect | Mar 25, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Purchase | +21.0K | $19.33 | $406K | 3.7Mdirect | Mar 25, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Purchase | +101.8K | $21.22 | $2.2M | 3.7Mdirect | Mar 21, 2014 | Feb 18, 2015 | Form 4 ↗ |
| Gregory Philip DSee Remarks | Sale | −15.0K | $22.38 | $336K | 109.3Kdirect | Mar 21, 2014 | Mar 25, 2014 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −17.8K | $24.28 | $432K | 3.7Mdirect | Mar 19, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −49.6K | $23.75 | $1.2M | 3.7Mdirect | Mar 18, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −34.4K | $23.74 | $818K | 3.7Mdirect | Mar 18, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Purchase | +52.2K | $23.02 | $1.2M | 3.7Mdirect | Mar 17, 2014 | Feb 18, 2015 | Form 4 ↗ |
| Ramasastry SairaDirector | Sale | −10.0K | $23.26 | $233K | 0direct | Mar 17, 2014 | Mar 17, 2014 | Form 4 ↗ |
| LANPHIER EDWARD O IIPresident & CEO · Director | Sale | −50.0K | $23.22 | $1.2M | 295.0Kdirect | Mar 17, 2014 | Mar 17, 2014 | Form 4 ↗ |
| Mento Steven JDirector | Sale | −6,103 | $22.77 | $139K | 23.6Kdirect | Mar 14, 2014 | Mar 17, 2014 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Purchase | +71.3K | $22.76 | $1.6M | 3.7Mdirect | Mar 13, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −123.5K | $23.40 | $2.9M | 3.7Mdirect | Mar 12, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Purchase | +12.5K | $22.30 | $279K | 3.7Mdirect | Mar 10, 2014 | Feb 18, 2015 | Form 4 ↗ |
| Wolff Henry WardExec VP & CFO | Sale | −10.0K | $22.31 | $223K | 227.3Kdirect | Mar 10, 2014 | Mar 12, 2014 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Purchase | +258.4K | $22.25 | $5.7M | 3.7Mdirect | Mar 7, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −21.0K | $24.10 | $506K | 3.7Mdirect | Mar 6, 2014 | Feb 18, 2015 | Form 4 ↗ |
| RA Capital Healthcare Fund LP | Sale | −40.5K | $24.10 | $976K | 3.7Mdirect | Mar 6, 2014 | Feb 18, 2015 | Form 4 ↗ |
| Kolchinsky Peter | Sale | −20.4K | $24.00 | $490K | 3.7Mdirect | Mar 6, 2014 | Feb 18, 2015 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →